UA47974U - Method for controlled treatment of alzheimer disease type i with pyoglitason in insulin resistant patients - Google Patents

Method for controlled treatment of alzheimer disease type i with pyoglitason in insulin resistant patients

Info

Publication number
UA47974U
UA47974U UAU200910995U UAU200910995U UA47974U UA 47974 U UA47974 U UA 47974U UA U200910995 U UAU200910995 U UA U200910995U UA U200910995 U UAU200910995 U UA U200910995U UA 47974 U UA47974 U UA 47974U
Authority
UA
Ukraine
Prior art keywords
pyoglitason
alzheimer disease
disease type
insulin resistant
controlled treatment
Prior art date
Application number
UAU200910995U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Семен Михайлович Расин
Игорь Петрович Кайдашев
Михаил Сахнович Расин
Алексей Михайлович Расин
Original Assignee
Семен Михайлович Расин
Игорь Петрович Кайдашев
Михаил Сахнович Расин
Алексей Михайлович Расин
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Семен Михайлович Расин, Игорь Петрович Кайдашев, Михаил Сахнович Расин, Алексей Михайлович Расин filed Critical Семен Михайлович Расин
Priority to UAU200910995U priority Critical patent/UA47974U/en
Publication of UA47974U publication Critical patent/UA47974U/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A method for the controlled treatment of Alzheimer disease type I with Pyoglitason in insulin resistant patients provides for long-term use of Pyoglitason at a dose of 15 mg daily in the patients with the early stage of Alzheimer disease type I and diabetes mellitus type 2 or increased C-peptide blood content.
UAU200910995U 2009-10-30 2009-10-30 Method for controlled treatment of alzheimer disease type i with pyoglitason in insulin resistant patients UA47974U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU200910995U UA47974U (en) 2009-10-30 2009-10-30 Method for controlled treatment of alzheimer disease type i with pyoglitason in insulin resistant patients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU200910995U UA47974U (en) 2009-10-30 2009-10-30 Method for controlled treatment of alzheimer disease type i with pyoglitason in insulin resistant patients

Publications (1)

Publication Number Publication Date
UA47974U true UA47974U (en) 2010-02-25

Family

ID=50693336

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU200910995U UA47974U (en) 2009-10-30 2009-10-30 Method for controlled treatment of alzheimer disease type i with pyoglitason in insulin resistant patients

Country Status (1)

Country Link
UA (1) UA47974U (en)

Similar Documents

Publication Publication Date Title
WO2011020319A8 (en) Fusion protein regulating plasma glucose and lipid, its preparation method and use
PL1808168T3 (en) Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
MX2008013304A (en) Glp-1 compounds.
MX2022001797A (en) Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug.
PH12016500606A1 (en) Insulin preparations containing methionine
NZ608829A (en) Pharmaceutical composition comprising an sglt2-inhibitor, methods for treating and uses thereof
MX2019006731A (en) Use of ultrarapid acting insulin.
NZ596041A (en) Use of guanethidine for treating hypertension by local vascular delivery
NZ603399A (en) Pegylated c-peptide
TW200740452A (en) Therapeutic gastrodia extracts
MX2012006744A (en) Ppar-sparing thiazolidinediones and combinations for the treatment of diabetes mellitus and other metabolic diseases.
UA105191C2 (en) Treatment with pirfenidone of patients with abnormal liver function
HK1143066A1 (en) Ranolazine for elevated brain-type natriuretic peptide
UA47974U (en) Method for controlled treatment of alzheimer disease type i with pyoglitason in insulin resistant patients
DK1675611T3 (en) Therapeutic uses for C-peptide
SG159462A1 (en) Multi-herbal medicinal composite for treating the metabolic syndrome and preparation method thereof
UA35558U (en) Method for treating candidiasis of oral mucosa in patients with diabetes mellitus
AU2011213703B2 (en) Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
RU2008107113A (en) MEANS AND METHOD FOR PREVENTION AND TREATMENT OF PATIENTS WITH ALZHEIMER'S DISEASE
HK1135030A1 (en) Composition useful for the treatment of type 2 diabetes
UA54839U (en) Method for treating psoriasis
UA57509U (en) Method for treating hyperhomocysteinuria in patients with ischemic heart disease with concomitant diabetes mellitus type 2
Salzer ID corner: Helicobacter pylori infection
UA48148U (en) method for treatment of worsening of the chronic pyelonephritis in combination with the diabetes mellitus of 2 type
UA49068U (en) Method for treating patients with chronic non-calculous cholecystitis with concomitant diabetes mellitus type 2